Takeda Sued In U.S. For Failing To Report Actos Heart-Failure Cases
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical’s U.S. unit is accused in a whistleblower suit of failing to report hundreds of congestive heart-failure incidents associated with its blockbuster Actos (pioglitazone).